Skip to content

Immunovant, Inc.

IMVT Nasdaq SEC CIK 1764013

Follow Immunovant Weekly email: filings, results, news

News

3 stories filed under Immunovant

Markets

Thread · 2 stories · active today

Immunovant stock falls after lupus drug trial misses goal

Markets 13 h ago 3 sources

Why is Immunovant stock sliding today?

Markets 1 d ago

More coverage

Immunovant, Inc. (IMVT) Q1 2027 Earnings Call Transcript

Earnings 49 d ago 2 sources

Profile

Headquarters: DURHAM, NC, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Peers

Where this page comes from

Profile · SEC EDGAR

News · 3 stories clustered from the RSS aggregator